Asahi Life Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Asahi Life Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$442K	Buy	+709	New	+$483K	0.25%	92
2025 Q4	–	Sell	-782	Closed	-$440K	–	191
2025 Q3	$440K	Sell	782 -63	-7%	-$35.6K	0.24%	87
2025 Q2	$444K	Buy	845 +160	+23%	+$89.3K	0.26%	88
2025 Q1	$434K	Buy	+685	New	+$471K	0.28%	74
2024 Q2	–	Sell	-227	Closed	-$218K	–	204
2024 Q1	$218K	Buy	+227	New	+$216K	0.13%	164
2023 Q3	–	Sell	-560	Closed	-$402K	–	230
2023 Q2	$402K	Sell	560 -80	-13%	-$61.7K	0.13%	82
2023 Q1	$526K	Buy	+640	New	+$483K	0.17%	67
2022 Q3	–	Sell	-200	Closed	-$118K	–	294
2022 Q2	$118K	Sell	200 -630	-76%	-$410K	0.03%	231
2022 Q1	$580K	Buy	+830	New	+$525K	0.08%	69
2021 Q3	–	Sell	-1,060	Closed	-$592K	–	289
2021 Q2	$592K	Buy	1,060 +155	+17%	+$78.5K	0.08%	62
2021 Q1	$428K	Sell	905 -150	-14%	-$73K	0.06%	128
2020 Q4	$510K	Buy	+1,055	New	+$569K	0.07%	105
2019 Q4	–	Sell	-1,350	Closed	-$374K	–	256
2019 Q3	$374K	Buy	+1,350	New	+$399K	0.06%	110

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Asahi Life Asset Management's REGN Position: Q2 2026 in Review

Asahi Life Asset Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 709 shares worth $442K. The stake represents 0.25% of the portfolio and ranks #92 among its holdings. This is a return to the name: Asahi Life Asset Management previously reported a position in REGN as recently as Q3 2025.

Asahi Life Asset Management first reported a position in REGN in Q3 2019 and has held it in 13 quarters since. The position peaked at $592K in Q2 2021. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Asahi Life Asset Management held 709 shares of Regeneron Pharmaceuticals worth $442K as of Q2 2026.
Regeneron Pharmaceuticals was a new Asahi Life Asset Management position in Q2 2026.
Regeneron Pharmaceuticals made up 0.25% of Asahi Life Asset Management's portfolio in Q2 2026, its #92 holding.
Asahi Life Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
Asahi Life Asset Management's Regeneron Pharmaceuticals position peaked at $592K in Q2 2021.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.